Check out our most popular compounded medications! Get Started
Flecainide Acetate 5 mg/ml Oral Liquid is a specially compounded medication designed for oral use, offering a precise and manageable method of drug delivery. This liquid formulation is particularly beneficial for patients who experience difficulty swallowing tablets or capsules, such as those in pediatric and geriatric groups. Flecainide Acetate is an antiarrhythmic agent used to prevent and treat a variety of cardiac arrhythmias, including supraventricular tachycardia, atrial fibrillation, and atrial flutter.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Flecainide Acetate 5 mg/ml Oral Liquid is a specially compounded medication designed for oral use, providing patients with an alternative to tablet or capsule forms of flecainide. This liquid formulation is particularly beneficial for individuals who have difficulty swallowing pills, such as pediatric and geriatric patients, or those with dysphagia. The liquid form allows for precise dosing, which is critical for the management of the conditions flecainide is indicated for.
Flecainide is a class 1C antiarrhythmic agent used to prevent and treat a variety of irregular heartbeats, such as supraventricular arrhythmias, including atrial fibrillation and atrial flutter, and ventricular arrhythmias. It works by slowing electrical impulses in the heart, stabilizing the heart rhythm, and is often prescribed when other medications have been ineffective or cannot be used. The efficacy of flecainide in treating arrhythmias has been well-documented, and its use must be closely monitored by a healthcare provider due to the potential for proarrhythmic effects, especially in patients with structural heart disease or myocardial ischemia.
When prescribing Flecainide Acetate 5 mg/ml Oral Liquid, it is important for healthcare providers to consider the patient's cardiac history, current medications, and potential drug interactions. Regular monitoring of the patient's cardiac status, including ECG and possibly blood levels of flecainide, is recommended to ensure therapeutic effectiveness and to minimize the risk of adverse effects. Patients should be counseled on the importance of adhering to the prescribed dosing schedule and to report any unusual symptoms or side effects to their healthcare provider immediately.
Bayview Pharmacy's team of compounding pharmacists ensures that each batch of Flecainide Acetate 5 mg/ml Oral Liquid is prepared to the highest standards of quality and consistency. We are available to answer any questions or concerns from both patients and prescribers regarding this formulation. Our goal is to provide a tailored medication solution that meets the specific needs of each patient, ensuring both safety and efficacy in the treatment of arrhythmias. If you have any questions or require further information, please do not hesitate to reach out to us.
Flecainide acetate is an antiarrhythmic medication used to prevent and treat a variety of irregular heartbeats, such as atrial fibrillation, atrial flutter, and ventricular tachycardia. It works by stabilizing the heart's electrical activity, thereby helping to maintain a normal rhythm. When considering the use of flecainide acetate in a 5 mg/ml oral liquid formulation, it is crucial to be aware of potential drug interactions that may affect its efficacy and safety.
One significant interaction is with medications that inhibit the cytochrome P450 2D6 (CYP2D6) enzyme, such as quinidine, selective serotonin reuptake inhibitors (SSRIs), and certain beta blockers. These drugs can increase flecainide levels in the body, potentially leading to toxicity. Conversely, medications that induce CYP2D6, like rifampin and phenytoin, may decrease flecainide plasma levels, reducing its effectiveness. It is also important to monitor the use of other antiarrhythmic drugs, as combining them with flecainide can heighten the risk of cardiac side effects.
Patients taking flecainide should avoid class I antiarrhythmic drugs, as the combination can exacerbate cardiac conditions. Additionally, the concurrent use of flecainide with drugs that prolong the QT interval, such as certain antipsychotics or antibiotics, can increase the risk of a potentially life-threatening arrhythmia called torsades de pointes. Care should also be taken when flecainide is used with digoxin, as it can raise digoxin levels, necessitating close monitoring of serum digoxin concentrations.
Calcium channel blockers and beta blockers, when used with flecainide, can lead to additive negative effects on cardiac conduction and contractility. This combination requires careful titration and monitoring. Furthermore, the use of flecainide with anticoagulants, such as warfarin, may necessitate adjustments in anticoagulant dosage due to potential changes in prothrombin time or INR.
Patients should be advised to avoid grapefruit juice while taking flecainide, as it can interfere with the metabolism of the drug, leading to increased levels in the bloodstream. Additionally, electrolyte imbalances, particularly hypokalemia or hypomagnesemia, can potentiate the effects of flecainide and should be corrected prior to initiating therapy.
It is essential for patients and prescribers to be aware of all medications, supplements, and over-the-counter drugs being taken to avoid potential interactions with flecainide. Regular monitoring, including electrocardiograms and possibly blood levels of flecainide, may be necessary to ensure safe and appropriate use of this medication. If you have any questions or concerns regarding the use of flecainide acetate 5 mg/ml oral liquid or its interactions with other drugs, please reach out to us at Bayview Pharmacy for further assistance.
Flecainide Acetate is an antiarrhythmic medication that works by stabilizing the heart's electrical activity. When formulated as a 5 mg/ml oral liquid, it provides a precise dosage in a form that is easy to administer, especially for patients who have difficulty swallowing pills or tablets. This liquid formulation is particularly beneficial for pediatric and geriatric patients, or those with dysphagia or other conditions that impair their ability to swallow solid forms of medication.
The mechanism of action of Flecainide involves the inhibition of sodium channels in the cardiac cells. By blocking these channels, Flecainide slows the conduction of electrical impulses through the heart, which helps to restore a normal rhythm in patients with arrhythmias. This effect can be crucial in treating conditions such as atrial fibrillation, paroxysmal supraventricular tachycardia (PSVT), and other similar cardiac arrhythmias. The goal of treatment with Flecainide is to maintain a steady and regular heartbeat, thereby reducing symptoms such as palpitations, dizziness, and shortness of breath associated with arrhythmias.
When using the Flecainide Acetate oral liquid formulation, it is important to adhere to the prescribed dosage and administration schedule to ensure optimal therapeutic outcomes. The liquid form allows for flexible dosing, which can be adjusted according to the specific needs of the patient. Additionally, the liquid formulation ensures that the medication is absorbed quickly and efficiently, providing rapid onset of action, which is often critical in managing acute episodes of arrhythmia.
It is essential for both patients and prescribers to be aware of the potential side effects and interactions associated with Flecainide. Monitoring of cardiac function and adjustment of dosage may be necessary to minimize risks and achieve the best therapeutic results. Patients should also be counseled on the importance of maintaining consistent blood levels of the medication, which can be facilitated by the use of a liquid formulation, as it allows for more accurate dosing compared to cutting or splitting tablets.
For any questions or concerns regarding the use of Flecainide Acetate 5 mg/ml Oral Liquid, or to discuss the suitability of this formulation for a specific patient, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is dedicated to providing comprehensive support and guidance to ensure the safe and appropriate use of this medication.
Flecainide Acetate 5 mg/ml Oral Liquid is a medication used to prevent and treat certain types of serious, life-threatening ventricular arrhythmias—abnormal heart rhythms. It works by stabilizing the heart muscle's electrical activity, thereby helping to maintain a normal rhythm.
The medication should be taken exactly as prescribed by your healthcare provider. The liquid form of this medication allows for accurate dosing and should be measured with an appropriate measuring device. It is usually taken twice daily. Do not use household spoons to measure the dose.
Yes, Flecainide Acetate Oral Liquid can be taken with or without food. However, it's important to take it consistently in relation to meals to maintain steady absorption.
If you miss a dose of Flecainide Acetate Oral Liquid, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not double up to make up for a missed dose.
Like all medications, Flecainide Acetate Oral Liquid can cause side effects. Common side effects include dizziness, visual disturbances, nausea, and fatigue. If you experience severe side effects or signs of an allergic reaction, seek medical attention immediately.
No, you should not stop taking Flecainide Acetate Oral Liquid suddenly without consulting your healthcare provider, as this may cause your condition to become worse. If you need to stop the medication, your doctor will advise you on how to taper off safely.
Flecainide Acetate Oral Liquid can be prescribed for both pediatric and geriatric patients. The liquid formulation is especially suitable when swallowing solid dosage forms is challenging or not possible. Dosage adjustments might be necessary depending on weight and health condition, especially in these populations.
Flecainide Acetate Oral Liquid may cause dizziness or vision problems, which could impair your ability to drive or operate heavy machinery. It is best to avoid these activities until you know how the medication affects you.
Flecainide Acetate Oral Liquid should be stored at room temperature, away from direct light, heat, and moisture. Keep the bottle tightly closed and out of the reach of children and pets.
Inform your healthcare provider about your complete medical history, especially if you have heart, liver, or kidney problems; or if you are taking any other medications, including over-the-counter drugs and herbal supplements. This will help your provider assess your suitability for Flecainide Acetate Oral Liquid and determine the appropriate dose for your condition.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
